Subscribe To
COPHF / Creso Pharma psychedelics subsidiary Halucenex lodges CTA to test efficacy of psilocybin on treatment-resistant PTSD
Content Topics
Global
Payments
Inc
0iw7
Pharma
Psychedelics
Subsidiary
Halucenex
Lodges
Efficacy
Psilocybin
Treatment resistant
Stock
COPHF
COPHF News
By Proactive Investors
July 18, 2022
Creso Pharma psychedelics subsidiary Halucenex Life Sciences broadens scope ahead of Phase 2 clinical trials
Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF) (Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF), Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF)) subsidiary Halucenex Life more_horizontal
By Proactive Investors
February 7, 2022
Creso Pharma subsidiary on official list to provide psilocybin to Canadian doctors
Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF)'s wholly-owned, Canadian-based psychedelics subsidiary Halucenex Life Sciences Inc. has been included on a li more_horizontal
By Proactive Investors
February 7, 2022
Creso Pharma subsidiary on official list to provide psilocybin to Canadian doctors
Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF)'s wholly-owned, Canadian-based psychedelics subsidiary Halucenex Life Sciences Inc. has been included on a li more_horizontal
By Proactive Investors
February 7, 2022
Creso Pharma subsidiary on official list to provide psilocybin to Canadian doctors
Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF)'s wholly-owned, Canadian-based psychedelics subsidiary Halucenex Life Sciences Inc. has been included on a li more_horizontal
By Benzinga
February 4, 2022
Australian Creso Pharma To Enter US CBD Market Via $21M Acquisition Of Sierra Sage Herbs
Cannabis company Creso Pharma Limited (ASX: CPH) (OTC: COPHF) (FRA:1X8) is entering the US CBD market, following a purchase agreement to acquire Color more_horizontal
By Benzinga
February 4, 2022
Australian Creso Pharma To Enter US CBD Market Via $21M Acquisition Of Sierra Sage Herbs
Cannabis company Creso Pharma Limited (ASX: CPH) (OTC: COPHF) (FRA:1X8) is entering the US CBD market, following a purchase agreement to acquire Color more_horizontal
By Benzinga
February 4, 2022
Australian Creso Pharma To Enter US CBD Market Via $21M Acquisition Of Sierra Sage Herbs
Cannabis company Creso Pharma Limited (ASX: CPH) (OTC: COPHF) (FRA:1X8) is entering the US CBD market, following a purchase agreement to acquire Color more_horizontal
By Proactive Investors
February 2, 2022
Creso Pharma pushes into US CBD market with revenue-generating acquisition
Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF) has entered the US CBD market. The company has executed a Membership Interest Purchase Agreement to acquire Co more_horizontal